• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?

作者信息

Alexander James L, Powell Nick

机构信息

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.

Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Department of Gastroenterology, Imperial College Healthcare NHS Trust, London, UK.

出版信息

Lancet Gastroenterol Hepatol. 2021 Jul;6(7):528-529. doi: 10.1016/S2468-1253(21)00184-9. Epub 2021 May 26.

DOI:10.1016/S2468-1253(21)00184-9
PMID:34048723
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8149174/
Abstract
摘要

相似文献

1
SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?炎症性肠病免疫抑制患者的新型冠状病毒2型疫苗接种：我们的方法应该改变吗？
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):528-529. doi: 10.1016/S2468-1253(21)00184-9. Epub 2021 May 26.
2
SARS-CoV-2 vaccination for patients with inflammatory bowel disease.针对炎症性肠病患者的新型冠状病毒2型疫苗接种
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):523. doi: 10.1016/S2468-1253(21)00148-5.
3
[SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].[成人炎症性肠病患者的新型冠状病毒2型疫苗接种：韩国炎症性肠病学会专家共识声明]
Korean J Gastroenterol. 2021 Aug 25;78(2):117-128. doi: 10.4166/kjg.2021.110.
4
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply.炎症性肠病患者的新型冠状病毒2型疫苗接种——作者回复
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):523-524. doi: 10.1016/S2468-1253(21)00194-1.
5
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.炎症性肠病患者的 SARS-CoV-2 疫苗接种：英国胃肠病学会炎症性肠病分会和 IBD 临床研究小组立场声明。
Lancet Gastroenterol Hepatol. 2021 Mar;6(3):218-224. doi: 10.1016/S2468-1253(21)00024-8. Epub 2021 Jan 26.
6
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.炎症性肠病患者的新型冠状病毒2型疫苗接种：一项国际共识会议的建议
Gut. 2021 Apr;70(4):635-640. doi: 10.1136/gutjnl-2020-324000. Epub 2021 Jan 20.
7
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.肠道微生物组和代谢组与免疫抑制性炎症性肠病患者 COVID-19 疫苗诱导的抗体反应减弱有关。
EBioMedicine. 2023 Feb;88:104430. doi: 10.1016/j.ebiom.2022.104430. Epub 2023 Jan 10.
8
Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease.炎症性肠病患者对三剂严重急性呼吸综合征冠状病毒2疫苗接种的血清学反应。
Gut. 2023 Apr;72(4):802-804. doi: 10.1136/gutjnl-2022-327440. Epub 2022 May 23.
9
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.COVID-19 疫苗接种后第三剂后炎症性肠病免疫抑制患者的抗体和 T 细胞反应（VIP）：一项多中心、前瞻性、病例对照研究。
Lancet Gastroenterol Hepatol. 2022 Nov;7(11):1005-1015. doi: 10.1016/S2468-1253(22)00274-6. Epub 2022 Sep 9.
10
Determinants of uptake of a third dose of SARS-CoV-2 vaccines in patients with inflammatory bowel disease.炎症性肠病患者接种第三剂SARS-CoV-2疫苗的影响因素。
Lancet Gastroenterol Hepatol. 2022 Jun;7(6):507. doi: 10.1016/S2468-1253(22)00120-0. Epub 2022 Apr 6.

引用本文的文献

1
Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease.2019冠状病毒病疫苗在炎症性肠病患者中的有效性和安全性
Gastroenterol Hepatol (N Y). 2022 Mar;18(3):145-155.
2
Review of COVID-19 viral vector-based vaccines and COVID-19 variants.基于新冠病毒载体的疫苗及新冠病毒变异株综述。
Infez Med. 2021 Sep 10;29(3):328-338. doi: 10.53854/liim-2903-3. eCollection 2021.
3
Risk, Course, and Effect of SARS-CoV-2 Infection in Children and Adults with Chronic Inflammatory Bowel Diseases.患有慢性炎症性肠病的儿童和成人感染新型冠状病毒的风险、病程及影响
Children (Basel). 2021 Aug 30;8(9):753. doi: 10.3390/children8090753.
4
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses.2019冠状病毒病与免疫介导的炎症性疾病：疾病及治疗对2019冠状病毒病结局和疫苗反应的影响
Lancet Rheumatol. 2021 Oct;3(10):e724-e736. doi: 10.1016/S2665-9913(21)00247-2. Epub 2021 Aug 27.
5
The next wave: immunizing the immunosuppressed.下一波：为免疫功能低下者接种疫苗。
Blood. 2021 Sep 2;138(9):746-747. doi: 10.1182/blood.2021013089.

本文引用的文献

1
Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases.脑静脉血栓形成与门静脉血栓形成：一项对537,913例新冠病毒病病例的回顾性队列研究。
EClinicalMedicine. 2021 Sep;39:101061. doi: 10.1016/j.eclinm.2021.101061. Epub 2021 Jul 31.
2
Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.丹麦和挪威接种牛津-阿斯利康 ChAdOx1-S 后动脉事件、静脉血栓栓塞、血小板减少和出血：基于人群的队列研究。
BMJ. 2021 May 5;373:n1114. doi: 10.1136/bmj.n1114.
3
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD.英夫利昔单抗与 IBD 患者对 BNT162b2 和 ChAdOx1 nCoV-19 SARS-CoV-2 疫苗的免疫原性降低有关。
Gut. 2021 Oct;70(10):1884-1893. doi: 10.1136/gutjnl-2021-324789. Epub 2021 Apr 26.
4
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.炎症性肠病患者的 SARS-CoV-2 疫苗接种：英国胃肠病学会炎症性肠病分会和 IBD 临床研究小组立场声明。
Lancet Gastroenterol Hepatol. 2021 Mar;6(3):218-224. doi: 10.1016/S2468-1253(21)00024-8. Epub 2021 Jan 26.
5
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.炎症性肠病活动期和缓解期的静脉血栓栓塞症：一项队列研究。
Lancet. 2010 Feb 20;375(9715):657-63. doi: 10.1016/S0140-6736(09)61963-2. Epub 2010 Feb 8.
6
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?炎症性肠病是血栓栓塞的独立且疾病特异性危险因素吗？
Gut. 2004 Apr;53(4):542-8. doi: 10.1136/gut.2003.025411.